October 21, 2021
Atossa Therapeutics, Breast Health

A Reminder To Get Your Mammograms from Atossa Therapeutics

Dr. Stephen Quay emphasizes the importance of breast health awareness, particularly during Breast Cancer Awareness Month in October. He highlights the impact of COVID-19 on mammography screenings, with many clinics closed over the past year, leading to missed appointments. Dr. Quay urges women to prioritize their health by scheduling their mammograms promptly, as early detection is crucial in breast cancer diagnosis and treatment. He encourages viewers to visit Atossa Therapeutics for more information on their clinical programs.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

CVille Right Now: Dr. Steven Quay on the Surprising Link Between Alcohol and Cancer

January 7, 2025

Surgeon General’s Breast Cancer Advisory Explained | Atossa Therapeutics Responds

January 6, 2025

(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies

A Conversation on Public Health Reform with Dr. Steven Quay

December 17, 2024

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!